A MUTATIONAL MODEL FOR CHILDHOOD CANCER
儿童癌症的突变模型
基本信息
- 批准号:6172344
- 负责人:
- 金额:$ 254.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-07-01 至 2004-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Overall Description (Applicant's Description) We have developed a multi- disciplinary program to investigate genetic susceptibility to childhood and associated cancer using genetic epidemiologic, cellular, and molecular techniques. The hypotheses are based on a multi-stage model for cancer, and are tested in two model familial syndromes of childhood and adolescent cancers, sarcomas and Li Fraumeni syndrome and its variants and Wilms' tumor of the kidney. or each tumor type, genetic loci have been identified that may be altered both as germline mutations and as tumor-specific mutations. There is also significant evidence for genetic heterogeneity, or involvement of additional cancer susceptibility loci. The underlying themes of the program include characterization of the underlying characterization of the underling cancer susceptibility, determination of the heritable contribution to each tumor, determination of the role and nature of genomic instability and genes that confer genomic instability in familial cancer syndromes, analysis of germline and somatic mutations by type and mechanism, development of animal models for human cancer susceptibility syndromes to explore evidence for modifier genes and developmental effects, and determination of the implications of germline mutations for the patients and their families. The findings from this program should provide insights into the mechanisms of carcinogenesis as well as guidelines for clinical programs for patients at high risk of cancer.
总体描述(申请人的描述)我们已经开发了一个多学科的项目,使用遗传流行病学、细胞和分子技术来研究儿童和相关癌症的遗传易感性。这些假设是基于癌症的多阶段模型,并在儿童和青少年癌症的两个模型家族综合征,肉瘤和Li Fraumeni综合征及其变体和肾母细胞瘤中进行了测试。或每种肿瘤类型,已经鉴定了可以作为生殖系突变和肿瘤特异性突变两者改变的遗传基因座。也有重要的证据表明遗传异质性,或涉及其他癌症易感性基因座。该计划的基本主题包括表征潜在癌症易感性的基本特征,确定对每种肿瘤的遗传贡献,确定基因组不稳定性的作用和性质以及赋予家族性癌症综合征基因组不稳定性的基因,按类型和机制分析种系和体细胞突变,开发人类癌症易感综合征的动物模型,以探索修饰基因和发育效应的证据,并确定生殖系突变对患者及其家庭的影响。该项目的研究结果应该为癌症发生机制提供见解,并为癌症高危患者的临床项目提供指导。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LOUISE C STRONG其他文献
LOUISE C STRONG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LOUISE C STRONG', 18)}}的其他基金
Genetic Epidemiology of Familial Childhood Cancer
家族性儿童癌症的遗传流行病学
- 批准号:
7118384 - 财政年份:2006
- 资助金额:
$ 254.92万 - 项目类别:
Patient Data and Sample Collection and Distribution
患者数据和样本采集和分发
- 批准号:
7118391 - 财政年份:2006
- 资助金额:
$ 254.92万 - 项目类别:
CORE--PATIENT DATA & SAMPLE COLLECTION, DISTRIBUTION AND PATHOLOGY REVIEW
核心——患者数据
- 批准号:
6357987 - 财政年份:2000
- 资助金额:
$ 254.92万 - 项目类别:
CORE--PATIENT DATA & SAMPLE COLLECTION, DISTRIBUTION AND PATHOLOGY REVIEW
核心——患者数据
- 批准号:
6198233 - 财政年份:1999
- 资助金额:
$ 254.92万 - 项目类别:
相似海外基金
The mechanism of oral carcinogenesis by FAT1 gene mutation
FAT1基因突变导致口腔癌的机制
- 批准号:
23K15977 - 财政年份:2023
- 资助金额:
$ 254.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an efficient method combining quantum chemistry and machine learning to evolve PCR technology and gene mutation analysis
开发一种结合量子化学和机器学习的有效方法来发展 PCR 技术和基因突变分析
- 批准号:
22KJ2450 - 财政年份:2023
- 资助金额:
$ 254.92万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of preemptive medicine for asymptomatic MEN1 gene mutation carriers
无症状MEN1基因突变携带者的抢先治疗药物开发
- 批准号:
23H03151 - 财政年份:2023
- 资助金额:
$ 254.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of molecular mechanisms of occurrence of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
- 批准号:
23K08067 - 财政年份:2023
- 资助金额:
$ 254.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the molecular mechanism of maxillofacial hypoplasia caused by FAT1 gene mutation
FAT1基因突变引起颌面发育不全的分子机制阐明
- 批准号:
22K19629 - 财政年份:2022
- 资助金额:
$ 254.92万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Association between CD79B gene mutation and prognosis in vitreoretinal lymphoma
CD79B基因突变与玻璃体视网膜淋巴瘤预后的关系
- 批准号:
22K09763 - 财政年份:2022
- 资助金额:
$ 254.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Gene mutation/expression prediction from clinical images using artificial intelligence technology in pancreatic cancer
利用人工智能技术从临床图像预测胰腺癌基因突变/表达
- 批准号:
20K17570 - 财政年份:2020
- 资助金额:
$ 254.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of colorectal carcinogenesis mediated by PTPRK gene mutation
PTPRK基因突变介导的结直肠癌发生机制的阐明
- 批准号:
20K16311 - 财政年份:2020
- 资助金额:
$ 254.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the molecular mechanism of development of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
- 批准号:
20K08953 - 财政年份:2020
- 资助金额:
$ 254.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of next-generation precision medicine targeting the pathways on which driver gene mutation-positive lung cancer depends
针对驱动基因突变阳性肺癌所依赖的途径开发下一代精准医疗
- 批准号:
20H03771 - 财政年份:2020
- 资助金额:
$ 254.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)